Xuelin (Steve) Wang
Lawyers
Filters
Laekna HK$791 million IPO
We advised Laekna on its IPO and HKEX listing
Cutia Therapeutics HK$412.9 million IPO
We advised Cutia on its IPO and HKEX listing
MedSci Healthcare Holdings HK$608 million IPO
We advised MedSci on its IPO and HKEX listing
TMS ¥2.9 billion global IPO
The shares are listed on the Tokyo Stock Exchange
Biocytogen HK$549 million IPO
We advised Biocytogen on its IPO and HKEX listing
Jiangsu Zhongnan Construction Group exchange offers
The exchange offers involve guaranteed senior notes due this year
Gracell Biotechnologies at-the-market offering
The ADSs are listed on the Nasdaq Global Select Market
Jiangsu Zhongnan Construction Group exchange offers and consent solicitation
The exchange offers and consent solicitation are for guaranteed senior notes
Laekna Therapeutics $61 million Series D financing
We are advising Laekna Therapeutics in connection with its Series D financing
Zhenro Properties exchange offer and consent solicitations
The consent solicitations involve notes and perpetual securities